Covalon Technology Limited (COV)

[lolabean]

I think some of the comparisons and misunderstanding is that COV is transitioning from a sales generated company to a 'royalty' generated company----based on the recent strategic relationship with Molnlycke. This might have had some effect on the previous quarter.

Molnlycke is the world leader in wound care products and would not have teamed up with COV and even paid them $3.5 million upfront-------if this was not something special.

Cov probably could have done a better job explaining this in their latest press release.

Zen will hopefully add more thoughts.